| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $65.1M | +47.8% |
| SG&A Expense | $45.4M | +15.7% |
| Operating Income | -$110.4M | -32.7% |
| Pre-tax Income | -$91.1M | -27.3% |
| Income Tax | $408K | +105.0% |
| Net Income | -$91.5M | -27.5% |
| EPS (Basic) | -$2.16 | -20.7% |
| EPS (Diluted) | -$2.16 | -20.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $143.2M | -47.6% |
| Current Assets | $191.7M | -35.1% |
| Total Assets | $197.3M | -34.4% |
| Current Liabilities | $15.6M | +3.2% |
| Total Liabilities | $16.0M | -2.9% |
| Stockholders' Equity | $181.3M | -36.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$105.5M | -55.7% |
| Capital Expenditures | $596K | +78.4% |
| Investing Cash Flow | -$596K | -78.4% |
| Financing Cash Flow | $1.0M | -99.3% |
| Free Cash Flow | -$106.0M | -55.8% |